NDTV Profit

Marksans Pharma


'Marksans Pharma' - 19 News Result(s)

  • Marksans Pharma Surges On FDA Nod For New Drug

    Marksans Pharma Surges On FDA Nod For New Drug

    Marksans Pharma shares surged as much as 12.5 per cent to hit intraday high of Rs 53.85 after the company announced that it has received US drug regulator's approval for a medicine used in treatment of sneezing, runny nose and other allergies.

  • Marksans Pharma Gets US Drug Regulator's Approval For Allergy Drug

    Marksans Pharma Gets US Drug Regulator's Approval For Allergy Drug

    In a BSE filing today, Marksans Pharma said, "USFDA has granted approval for an abbreviated new drug application (ANDA) for loratadine liquid filled capsules 10 mg."

  • Marksans Pharma Gets US Regulator's Nod For Diabetes Drug

    Marksans Pharma Gets US Regulator's Nod For Diabetes Drug

    Marksans Pharma has received approval from the US Food and Drug Administration (FDA) for its Metformin Hydrochloride tablets, used for treatment of diabetes, in the American market.

  • UK's Drug Regulator Issues Restricted GMP Certificate to Marksans Pharma

    UK's Drug Regulator Issues Restricted GMP Certificate to Marksans Pharma

    The company has received communication from UK's MHRA informing that they are issuing a 'Restricted GMP Certificate' allowing the company to continue manufacture and marketing of critical products for the UK markets, Marksans Pharma said in a BSE filing.

  • Marksans Pharma's Goa Plant Under UK Regulator Scanner

    Marksans Pharma's Goa Plant Under UK Regulator Scanner

    Marksans Pharma on Wednesday said UK health regulator has issued "certain observations" regarding the company's Goa facility, after inspecting it in November.

  • India Inc's Overseas Investment Dips 32% at $1.23 Billion in July

    India Inc's Overseas Investment Dips 32% at $1.23 Billion in July

    Among major investors, Manipal Health Systems Pvt Ltd invested $108.8 million in a joint venture in Singapore, Ballarpur Industries $75.08 million in a wholly-owned manufacturing facility in the Netherlands.

  • Marksans Pharma Surges 50% in Six Trading Sessions

    Marksans Pharma Surges 50% in Six Trading Sessions

    Marksans Pharma shares have been in demand Since June 30 after the company said that it had acquired US-based Time-Cap Laboratories for an undisclosed amount.

  • Marksans Pharma Surges 10% on Acquisition of US-Based Time-Cap

    Marksans Pharma Surges 10% on Acquisition of US-Based Time-Cap

    Marksans Pharma shares rose over 9 per cent to touch an intraday high of Rs 64.40 on Tuesday after the company said that it has acquired US-based Time-Cap Laboratories for an undisclosed amount..

  • Marksans Pharma reports net profit of Rs 5.08 crore in the March 2010 quarter

    Marksans Pharma reports net profit of Rs 5.08 crore in the March 2010 quarter

    Sales rise 82.30% to Rs 55.60 croreMarksans Pharma reported net profit of Rs 5.08 crore in the quarter ended March 2010 as against net loss of Rs 13.43 crore during the previous quarter ended March 2009. Sales rose 82.30% to Rs 55.60 crore in the quarter ended March 2010 as against Rs 30.50 crore during the previous quarter ended March 2009.For the...

  • Marksans Pharma''s board approves conversion of FCCBs into equity shares

    Marksans Pharma''s board approves conversion of FCCBs into equity shares

    On 14 April 2010 The board of Marksans Pharma in its meeting on 14 April 2010 has converted 1 Foreign Currency Convertible Bonds of US$ 1000 into 1,333 equity shares of Re. 1 each and allotted to the concerned bond holder.

  • Marksans Pharma net profit rises 527.78% in the December 2009 quarter

    Marksans Pharma net profit rises 527.78% in the December 2009 quarter

    Sales rise 24.07% to Rs 62.94 croreNet profit of Marksans Pharma rose 527.78% to Rs 1.13 crore in the quarter ended December 2009 as against Rs 0.18 crore during the previous quarter ended December 2008. Sales rose 24.07% to Rs 62.94 crore in the quarter ended December 2009 as against Rs 50.73 crore during the previous quarter ended December 2008. ...

  • Marksans Pharma net profit rises 527.78% in the December 2009 quarter

    Marksans Pharma net profit rises 527.78% in the December 2009 quarter

    Sales rise 24.07% to Rs 62.94 croreNet profit of Marksans Pharma rose 527.78% to Rs 1.13 crore in the quarter ended December 2009 as against Rs 0.18 crore during the previous quarter ended December 2008. Sales rose 24.07% to Rs 62.94 crore in the quarter ended December 2009 as against Rs 50.73 crore during the previous quarter ended December 2008. ...

  • Marksans Pharma reports net loss of Rs 3.53 crore in the September 2009 quarter

    Marksans Pharma reports net loss of Rs 3.53 crore in the September 2009 quarter

    Sales decline 40.95% to Rs 40.27 croreMarksans Pharma reported net loss of Rs 3.53 crore in the quarter ended September 2009 as against net profit of Rs 6.96 crore during the previous quarter ended September 2008. Sales declined 40.95% to Rs 40.27 crore in the quarter ended September 2009 as against Rs 68.20 crore during the previous quarter ended ...

  • Marksans Pharma's director retires

    Marksans Pharma's director retires

    With effect from 25 September 2009Marksans Pharma has announced that Kim Tan, Director of the Company has retired as a director of the company with effect from 25 September 2009.The company made this announcement after the trading hours today, 30 September 2009.

  • Marksans Pharma to raise funds

    Marksans Pharma to raise funds

    Through issue of securities The board of Marksans Pharma in its meeting on 29 December 2009 has decided to raise capital through issue of equity shares / equity shares through depository receipts / foreign currency convertible bonds / any other convertible bonds / securities upto an amount not exceeding US$125 million.

  • Marksans Pharma to raise funds

    Marksans Pharma to raise funds

    By issue of equity/equity linked instrumentsThe board of Marksans Pharma has decided to raise capital through issue of equity or equity linked instruments upto Rs. 200 Crores.This was decided at the board meeting held on 30 October 2009.

  • Marksans Pharma to raise funds

    Marksans Pharma to raise funds

    By issue of equity/equity linked instrumentsThe board of Marksans Pharma has decided to raise capital through issue of equity or equity linked instruments upto Rs. 200 Crores.This was decided at the board meeting held on 30 October 2009.

  • Marksans Pharma reports net loss of Rs 3.45 crore in the June 2009 quarter

    Marksans Pharma reports net loss of Rs 3.45 crore in the June 2009 quarter

    Marksans Pharma reported net loss of Rs 3.45 crore in the quarter ended June 2009 as against net profit of Rs 6.79 crore during the previous quarter ended June 2008. Sales declined 16.24% to Rs 45.33 crore in the quarter ended June 2009 as against Rs 54.12 crore during the previous quarter ended June 2008. ParticularsQuarter Ended Jun. 2009Jun. 20...